{{Rsnum
|rsid=4513299
|Chromosome=2
|position=114292241
|Orientation=plus
|GMAF=0.3871
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 35.7 | 42.0 | 22.3
| HCB | 44.9 | 49.3 | 5.9
| JPT | 41.6 | 48.7 | 9.7
| YRI | 37.0 | 47.3 | 15.8
| ASW | 42.1 | 42.1 | 15.8
| CHB | 44.9 | 49.3 | 5.9
| CHD | 45.4 | 43.5 | 11.1
| GIH | 41.6 | 45.5 | 12.9
| LWK | 34.5 | 51.8 | 13.6
| MEX | 36.2 | 48.3 | 15.5
| MKK | 33.3 | 50.0 | 16.7
| TSI | 32.4 | 49.0 | 18.6
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22228203
|Trait=None
|Title=A genome-wide association study of inflammatory biomarker changes in response to fenofibrate treatment in the Genetics of Lipid Lowering Drug and Diet Network.
|RiskAllele=
|Pval=0.000004
|OR=None
|ORtxt=None
|OA=1
}}

{{on chip | Affy GenomeWide 6}}